| Literature DB >> 29982551 |
Martijn J J Finken1, Manouk van der Steen2, Carolina C J Smeets2, Marie J E Walenkamp1, Christiaan de Bruin3, Anita C S Hokken-Koelega2, Jan M Wit3.
Abstract
Children born small for gestational age (SGA), defined as a birth weight and/or length below -2 SD score (SDS), comprise a heterogeneous group. The causes of SGA are multifactorial and include maternal lifestyle and obstetric factors, placental dysfunction, and numerous fetal (epi)genetic abnormalities. Short-term consequences of SGA include increased risks of hypothermia, polycythemia, and hypoglycemia. Although most SGA infants show catch-up growth by 2 years of age, ∼10% remain short. Short children born SGA are amenable to GH treatment, which increases their adult height by on average 1.25 SD. Add-on treatment with a gonadotropin-releasing hormone agonist may be considered in early pubertal children with an expected adult height below -2.5 SDS. A small birth size increases the risk of later neurodevelopmental problems and cardiometabolic diseases. GH treatment does not pose an additional risk.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29982551 DOI: 10.1210/er.2018-00083
Source DB: PubMed Journal: Endocr Rev ISSN: 0163-769X Impact factor: 19.871